Waisman Center
Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.

Transcriptome analysis using patient iPSC-derived skeletal myocytes: Bet1L as a new molecule possibly linked to neuromuscular junction degeneration in ALS

Suzuki, DVM, PhD, M. Transcriptome Analysis Using Patient IPSC-Derived Skeletal Myocytes: Bet1L As a New Molecule Possibly Linked to Neuromuscular Junction Degeneration in ALS.

Lynch, E. M., Robertson, S., FitzGibbons, C., Reilly, M., Switalski, C., Eckardt, A., Tey, S. R., Hayakawa, K., & Suzuki, M. (2021). Transcriptome analysis using patient iPSC-derived skeletal myocytes: Bet1L as a new molecule possibly linked to neuromuscular junction degeneration in ALS. Experimental neurology, 345, 113815. https://doi.org/10.1016/j.expneurol.2021.113815